Michael Solomon
Director/Board Member chez PROTARA THERAPEUTICS, INC.
Fortune : 106 265 $ au 31/03/2024
Postes actifs de Michael Solomon
Sociétés | Poste | Début | Fin |
---|---|---|---|
PROTARA THERAPEUTICS, INC. | Director/Board Member | 01/05/2018 | - |
Independent Dir/Board Member | 01/05/2018 | - | |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Director/Board Member | 01/10/2017 | - |
Chief Executive Officer | 01/10/2017 | - | |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Director/Board Member | 01/06/2021 | - |
Historique de carrière de Michael Solomon
Anciens postes connus de Michael Solomon
Sociétés | Poste | Début | Fin |
---|---|---|---|
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Corporate Officer/Principal | 01/12/2016 | 01/12/2018 |
DECIBEL THERAPEUTICS, INC. | Chief Operating Officer | 01/09/2015 | 01/01/2016 |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Chief Operating Officer | 01/01/2012 | 01/01/2015 |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2009 | 01/01/2012 |
EPIZYME, INC. | Founder | 01/11/2007 | 01/05/2009 |
Corporate Officer/Principal | 01/11/2007 | 01/05/2009 | |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Director/Board Member | 01/05/2018 | - |
░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Michael Solomon
University of Wisconsin | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 15 |
Opérationnelle
Corporate Officer/Principal | 6 |
Director/Board Member | 4 |
Chief Operating Officer | 2 |
Sectorielle
Health Technology | 10 |
Finance | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
DECIBEL THERAPEUTICS, INC. | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 10 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Hypnion, Inc.
Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA. | Commercial Services |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Headquartered in Charlotte, North Carolina, Banc of America Securities (BAS) is the investment banking subsidiary of Bank of America Corp (NYSE: BAC). The firm provides both the domestic and international equity and investment banking markets, and pursues a strategy pioneered by Citigroup that combines corporate lending with investment banking advice and services. They provide high-yield debt underwriting and leveraged finance, in addition to industry coverage groups such as healthcare, media and telecom, financial institutions, real estate and gaming. BAS also does a significant amount of work for Financial Sponsors, or private equity firms, often financing leveraged transactions. Following the strategy of Goldman Sachs, the firm lacks a standalone mergers and acquisitions department, instead employing mergers and acquisitions senior bankers throughout the industry coverage groups. The firm is registered as a broker/dealer with the SEC, is a member of the NYSE, and the NASD. The use of Banc in the BAS's name is indicative of the fact that the company is not a bank, and their deposits and other holdings are not insured by the FDIC. | Finance |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Finance |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Health Technology |
- Bourse
- Insiders
- Michael Solomon
- Expérience